Tribunals must not reject merger schemes at the first-motion stage for curable timing concerns.

HNPCL, an unlisted public company engaged in thermal power generation, and GOCL Corporation Limited, a listed public company, formulated a Scheme of Merger by Absorption under Sections 230–232 of the Companies Act, 2013, under which HNPCL was to merge into GOCL.

Since GOCL was listed, the Scheme was submitted to SEBI and the stock exchanges. SEBI’s observations were received on 20 May 2026, followed by the BSE and NSE observation letters on 20 May and 22 May 2026, respectively. The appellants filed the first-motion application before the NCLT on 22 June 2026.

The NCLT, Amravati Bench dismissed the application on 30 July 2026, principally on the grounds that the appointed date was more than one year prior to the filing date, certain discrepancies existed in the financial and other documents, and the application had been filed belatedly.

Whether the NCLT was justified in dismissing the first-motion Scheme application at the threshold on the ground that the appointed date was more than one year prior to the filing of the application, having regard to MCA General Circular No. 09/2019 dated 21 August 2019.

Whether the delay in filing the first-motion application, attributable substantially to the time taken for obtaining SEBI and stock-exchange observations mandated for a listed-company scheme, warranted dismissal of the application.

Whether the NCLT could determine issues relating to valuation, shareholder and creditor impact, and alleged documentary discrepancies conclusively at the first-motion stage, before the shareholders and creditors had considered the Scheme.

The Court applied Sections 230–232 of the Companies Act, 2013, governing compromises, arrangements and amalgamations, and Section 421, which provides the appellate jurisdiction invoked against the NCLT’s order.

Regulation 37 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 requires a listed company to obtain the requisite SEBI and stock-exchange observations before presenting the Scheme to the Tribunal.

MCA General Circular No. 09/2019 dated 21 August 2019 provides that where the appointed date is significantly ante-dated beyond one year from the filing date, the justification must be specifically stated in the Scheme and the arrangement must not be contrary to public interest.

The Court further treated the Circular as requiring an explanation of the ante-dating or delay, rather than creating an automatic jurisdictional bar to consideration of the Scheme.

The NCLAT held that the NCLT had addressed matters prematurely. A merger involves two stages: the first stage concerns placing the Scheme before shareholders and creditors, while the second stage permits more comprehensive scrutiny by the Tribunal, regulators and tax authorities.

Because GOCL was listed, the appellants could not effectively move the first-motion application until the mandatory SEBI and stock-exchange observations were available. The application was filed shortly after those observations were received, and the resulting interval could not fairly be attributed exclusively to default by the appellants.

The one-year requirement in Circular No. 09/2019 did not justify dismissal where the circumstances explaining the timing could be gathered from the Scheme and the Tribunal record; the Circular required justification and public-interest scrutiny, not automatic rejection.

Questions concerning any effect of delay on valuation, the interests of shareholders and creditors, and the adequacy of the financial information could be examined after the statutory meetings and during the second-motion proceedings.

Dismissing the application would also require the parties to recommence the process, despite the Scheme already having entered the regulatory and public domain, thereby creating an avoidable obstruction to the corporate restructuring process.

The NCLAT directed the NCLT to appoint the Chairman and scrutineers, fix their remuneration, and prescribe the schedule for the shareholder and creditor meetings within one week and, in any event, no later than 5 October 2026.

The Court left issues concerning valuation, regulatory scrutiny, creditor and shareholder impact, and other substantive objections to be considered at the appropriate subsequent stage. No order as to costs was made.